Life sciences · Interventional Study
ClinicalTrials.gov · September 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT01560871). This is a study registration, not published results. Lead sponsor: Texas Woman's University. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 16 participants (ACTUAL). Conditions: Heart Failure NYHA Class II, Heart Failure NYHA Class III. Interventions: BEHAVIORAL: High-intensity IMT plus walking; BEHAVIORAL: Low-intensity IMT plus walking. Primary outcome measures: Change From Baseline in Mean Minnesota Living With Heart Failure Questionnaire Score , Baseline and 6 weeks; Change From Baseline in Mean Score of Physical Component of the SF-36 Questionnaire , Baseline and 6 weeks. Brief summary: Individuals with chronic heart failure need a "safe and effective" exercise program that could enhance their quality of life. In this study, we examined whether an experimental exercise program of autonomous walking and high-intensity Inspiratory Muscle Training (IMT) could result in better effects on respiratory muscle strength (PImax), cardiovascular endurance, quality of life, and physical activity, when compared to autonomous walking and "sham" IMT program, in adults with chronic heart failure.